Origin and company scope
Kevin founded Diabetech after his daughter’s type 1 diabetes diagnosis in 2001. The initial problem was practical: useful glucose information existed with the patient, while parents and other caregivers often received it late or incompletely. His background in mobile platforms and telecommunications provided a foundation for connecting medical devices to remote information and support workflows.
Over the following 17 years, the work evolved from connected telemetry into virtual disease management and broader population-health engagement. The HealthCordia and Healthimo records describe these later phases separately so the development of the business remains visible.
Product and technology leadership
Kevin led hardware, software, and hosted/cloud product development for six wireless diabetes devices, including GlucoMON and GlucoMON-ADMS. His record describes architecture spanning medical-device interfaces, wireless transmission, remote device management, web applications, automated rules, caregiver alerts, and backend analytics.
The objective was to reduce the extra work required to share data and to make timely information available to the people supporting the patient. The product combined physical devices, network services, software, data, and clinical workflows rather than ending at the meter.
Evidence and field operations
The company operated research and care programs involving patients, clinicians, payers, employers, hospitals, and public programs. Kevin’s later career materials describe more than 20 observational, interventional, and population-health studies and programs, and more than $4 million invested in field testing. These are career-reported portfolio figures.
His responsibilities included technology and protocol design, training, support, outcomes analysis, partnership development, and—in selected studies—principal-investigator duties. The 2012 Diabetes Care randomized trial provides a public research example. Contemporary reporting and the patent record establish that the connected-care architecture was being developed well before remote monitoring became a familiar commercial category.
Business and operating model
Kevin owned product, partnerships, commercialization, and business execution. Programs integrated patient identification, enrollment, home diagnostics, device logistics, remote glucose data, support, clinical workflows, payer reporting, and reimbursement-related processes. Partnerships and programs involved organizations such as BellSouth/AT&T, Blue Cross Blue Shield of Texas, McKesson/Texas Medicaid, Kaiser Permanente, NHS collaborators, LifeScan, and regional health systems.
Commercial licensing and platform lineage are described in his career record as progressing through Telcare and BioTelemetry into Philips Virtual Care Management. The archive preserves that account while treating Philips’ current product announcement as market context rather than proof of every historical transaction.
What endured
The recurring principle was to connect observation, interpretation, communication, intervention, and feedback. The architecture made daily patient information useful beyond the device itself. Kevin carried that operating experience into sponsor-side clinical development at Ultragenyx and later work on patient narratives and operational signals.
Diabetech is both a technical origin and an operating-business record. It shows experience building a capability, obtaining partners and users, generating research evidence, and dealing with the practical conditions under which the system had to work.
Sources and record basis
- Peer-reviewed researchDiabetes Care · 2012 randomized controlled trial
A 12-month study of 48 children evaluated automated glucose-data collection and family feedback. Kevin McMahon is a co-author. The findings concern the intervention studied; they are not a claim about every later product.
- Patent applicationGoogle Patents · US20050038680A1
Names Kevin McMahon as inventor. Priority: December 19, 2002; filing: February 3, 2004; publication: February 17, 2005. The publication documents an architecture; it is not presented as an active granted patent.
- Independent reportingD CEO · Help for Diabetics, 2007
Contemporary reporting on Diabetech, wireless glucose data, rules, and patient-to-caregiver connectivity.
- Independent reportingDavid Mendosa · GlucoMON
Historical reporting on automated glucose transmission and family/caregiver notifications. Original-site access may vary.